15429
Boc-Asp(OtBu)-OH
≥99.0% (sum of enantiomers, TLC)
别名:
Boc-L-天冬氨酸-4-叔丁酯
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
(CH3)3COCOCH2CH[NH(COOC(CH3)3]COOH
化学文摘社编号:
分子量:
289.32
UNSPSC Code:
12352209
NACRES:
NA.22
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
2336144
产品名称
Boc-Asp(OtBu)-OH, ≥99.0% (sum of enantiomers, TLC)
InChI
1S/C13H23NO6/c1-12(2,3)19-9(15)7-8(10(16)17)14-11(18)20-13(4,5)6/h8H,7H2,1-6H3,(H,14,18)(H,16,17)/t8-/m0/s1
SMILES string
CC(C)(C)OC(=O)C[C@H](NC(=O)OC(C)(C)C)C(O)=O
InChI key
PHJDCONJXLIIPW-QMMMGPOBSA-N
assay
≥99.0% (sum of enantiomers, TLC)
form
powder
optical activity
[α]20/D +2.0±0.4°, c = 1% in methanol
reaction suitability
reaction type: Boc solid-phase peptide synthesis
mp
64-67 °C
application(s)
peptide synthesis
storage temp.
2-8°C
Quality Level
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
Shugo Yamashita et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 157, 85-96 (2020-10-12)
Bone-drug targeting therapies using nanoparticles based on targeting ligands remain challenging due to their uptake clearance at non-target sites such as the liver, kidney, and spleen. Furthermore, the distribution sites of nanoparticles in bones have not been fully investigated, thus
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持